Your source for the latest medtech news from AdvaMed® and our members.
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today issued the following statement from Ashley Wittorf, Executive Director, AdvaMed Accel® & Global Head, Investor Relations, on bipartisan legislation (HR 7917) introduced in the…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests reached approximately 100 million, as of July 25, based on the latest…
WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association® (AdvaMed®) announced that…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
AdvaMed® announced that shipments of COVID-19 molecular diagnostic tests reached one million per day for the week ending July 24, based on the latest data from the association’s National Testing Registry.
Whitaker Calls National Registry “Crucial Tool” for Federal, State Authorities; Announces More Than 65 Million Tests Shipped Nationwide Since Beginning of Pandemic WASHINGTON, D.C. – In its latest action to help ensure…
WASHINGTON, D.C. – In its latest action to help ensure the widespread availability of testing to detect and contain the coronavirus, the Advanced Medical Technology Association® (AdvaMed®) today announced the creation of…
WASHINGTON, D.C. – AdvaMed® today sent the following letter to Health and Human Services (HHS) Secretary Azar requesting that he extend the declared federal public health emergency (PHE) beyond its current…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
WASHINGTON, D.C. – Today, 340 organizations signed a letter urging Congressional leaders to make telehealth flexibilities created during the COVID-19 pandemic permanent. Those signing this multi-stakeholder letter include national and…